Who Owns Maravai LifeSciences Stock?
NASDAQ: MRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 99.08%
- Institutions (% of float)
- 106.82%
- Held by insiders
- 7.25%
- Institutional holders
- 248
- Institutions 92.8%
- Insiders 7.2%
- Public and other 0.0%
Who owns Maravai LifeSciences stock?
Institutional investors own about 99.1% of Maravai LifeSciences's shares, spread across 248 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 7.25% of MRVI.
The largest institutional holders are GTCR, LLC (13.52%), Blackrock Inc. (6.69%) and Braidwell LP (5.84%). Together, the top 10 institutions control 50.4% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their MRVI positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of MRVI
| Institution | Shares | % Held | Change |
|---|---|---|---|
| GTCR, LLC | 20.15M | 13.52% | 0.0% |
| Blackrock Inc. | 9.97M | 6.69% | +6.7% |
| Braidwell LP | 8.70M | 5.84% | -15.0% |
| 12 West Capital Management Lp | 7.06M | 4.74% | -2.8% |
| Millennium Management Llc | 6.51M | 4.37% | +294.6% |
| Vanguard Capital Management LLC | 5.28M | 3.55% | -3.0% |
| Ophir Asset Management Pty Ltd | 4.83M | 3.24% | +100.0% |
| Renaissance Technologies, LLC | 4.61M | 3.09% | +8.0% |
| Deutsche Bank AG | 4.30M | 2.89% | +401.6% |
| First Eagle Investment Management, LLC | 3.67M | 2.46% | +45.4% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of MRVI
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.71M | 2.49% |
| First Eagle Funds-First Eagle Small Cap Opportunity Fund | 3.24M | 2.18% |
| iShares Trust-iShares Russell 2000 ETF | 2.93M | 1.96% |
| General American Investors Company, Inc. | 1.72M | 1.15% |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | 1.60M | 1.07% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.46M | 0.98% |
| Meridian Fund Inc-Meridian Contrarian Fund | 1.27M | 0.86% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.26M | 0.85% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.23M | 0.83% |
| ROYCE MICRO-CAP TRUST, INC.-Royce Micro-Cap Trust Inc | 1.14M | 0.76% |
Frequently asked questions
Who is the largest shareholder of Maravai LifeSciences?
GTCR, LLC is the largest institutional shareholder of MRVI, owning 13.52% of shares outstanding (20.15M shares) as of its latest 13F filing.
What percentage of Maravai LifeSciences is owned by institutions?
Institutions own about 99.1% of MRVI shares and 106.8% of the public float.
How much of Maravai LifeSciences do insiders own?
Insiders, such as officers and directors, own about 7.25% of MRVI shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.